164 related articles for article (PubMed ID: 18204475)
1. Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1.
Murthy KS
Br J Pharmacol; 2008 Mar; 153(6):1214-24. PubMed ID: 18204475
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A.
Murthy KS; Sriwai W
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G327-35. PubMed ID: 18006600
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
Murthy KS
J Pharmacol Exp Ther; 2008 Apr; 325(1):183-9. PubMed ID: 18180373
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of multidrug resistance protein 5 and phosphodiesterase 5 and regulation of cGMP levels in phasic and tonic smooth muscle.
Al-Shboul O; Mahavadi S; Sriwai W; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G314-24. PubMed ID: 23764893
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MLC20 phosphorylation downstream of Ca2+ and RhoA: A novel mechanism involving phosphorylation of myosin phosphatase interacting protein (M-RIP) by PKG and stimulation of MLC phosphatase activity.
Mahavadi S; Nalli A; Al-Shboul O; Murthy KS
Cell Biochem Biophys; 2014 Jan; 68(1):1-8. PubMed ID: 23723008
[TBL] [Abstract][Full Text] [Related]
6. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
Aburima A; Walladbegi K; Wake JD; Naseem KM
J Thromb Haemost; 2017 Aug; 15(8):1668-1678. PubMed ID: 28509344
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RhoA-dependent pathway and contraction by endogenous hydrogen sulfide in rabbit gastric smooth muscle cells.
Nalli AD; Rajagopal S; Mahavadi S; Grider JR; Murthy KS
Am J Physiol Cell Physiol; 2015 Mar; 308(6):C485-95. PubMed ID: 25567809
[TBL] [Abstract][Full Text] [Related]
8. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
9. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells.
Wilson LS; Guo M; Umana MB; Maurice DH
Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.
Rybalkin SD; Rybalkina IG; Feil R; Hofmann F; Beavo JA
J Biol Chem; 2002 Feb; 277(5):3310-7. PubMed ID: 11723116
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.
Nalli AD; Bhattacharya S; Wang H; Kendig DM; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G330-G341. PubMed ID: 28705807
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
Corbin JD; Turko IV; Beasley A; Francis SH
Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
[TBL] [Abstract][Full Text] [Related]
13. Cross-regulation of VPAC(2) receptor desensitization by M(3) receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2.
Huang J; Mahavadi S; Sriwai W; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G867-74. PubMed ID: 17170028
[TBL] [Abstract][Full Text] [Related]
14. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
[TBL] [Abstract][Full Text] [Related]
15. Increased PDE5 activity and decreased Rho kinase and PKC activities in colonic muscle from caveolin-1-/- mice impair the peristaltic reflex and propulsion.
Mahavadi S; Bhattacharya S; Kumar DP; Clay C; Ross G; Akbarali HI; Grider JR; Murthy KS
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G964-74. PubMed ID: 24157969
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic drugs regulate the PKG-II-dependent phosphorylation of M3 muscarinic acetylcholine receptors at plasma membranes from airway smooth muscle.
Alfonzo MJ; Alfonzo RG; Alfonzo González M; de Becemberg IL
J Recept Signal Transduct Res; 2015; 35(4):319-28. PubMed ID: 26053513
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA.
Murthy KS; Zhou H; Grider JR; Makhlouf GM
Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G1006-16. PubMed ID: 12736149
[TBL] [Abstract][Full Text] [Related]
18. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
Mullershausen F; Russwurm M; Koesling D; Friebe A
Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
[TBL] [Abstract][Full Text] [Related]
19. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
Morelli A; Filippi S; Sandner P; Fibbi B; Chavalmane AK; Silvestrini E; Sarchielli E; Vignozzi L; Gacci M; Carini M; Vannelli GB; Maggi M
J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
[TBL] [Abstract][Full Text] [Related]
20. Modulation of soluble guanylate cyclase activity by phosphorylation.
Murthy KS
Neurochem Int; 2004 Nov; 45(6):845-51. PubMed ID: 15312978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
